Meanwhile, the construction of a pharmaceutical manufacturing laboratory worth €2.5m in The Gambia has kicked off as a result of Spanish manufacturing firm Toskani's involvement.
The Gambian government spends high amounts of money to buy drugs from overseas and this new plant could be highly beneficial for the country in terms of healthcare provision.
The construction of the new facility, located in the city of Brikama, is expected to be completed in July next year.
The Gambian government is believed to have allocated a piece of land as part of its contribution towards the project.
The provision of drugs at affordable prices is a challenge for developing countries as regulations are not always well defined and therefore quality control standards have to be enforced, in order for a local production to be viable.
Meanwhile, the construction of a pharmaceutical manufacturing laboratory worth €2.5m in The Gambia has kicked off as a result of Spanish manufacturing firm Toskani's involvement.
The Gambian government spends high amounts of money to buy drugs from overseas and this new plant could be highly beneficial for the country in terms of healthcare provision.
The construction of the new facility, located in the city of Brikama, is expected to be completed in July next year.
The Gambian government is believed to have allocated a piece of land as part of its contribution towards the project.
The provision of drugs at affordable prices is a challenge for developing countries as regulations are not always well defined and therefore quality control standards have to be enforced, in order for a local production to be viable.